Viscosupplementation Market to Hit $2.6 Billion by 2021

Sep 21, 2015, 00:45 ET from RnR Market Research

PUNE, India, September 21, 2015 /PRNewswire/ --

MediPoint: Viscosupplementation - Global Analysis and Market Forecasts is a 2015 market research study that says competitive landscape in the viscosupplementation market space can be quite different across the geographies covered in this report.

Complete report on viscosupplementation market spread across 201 pages, listing 23 major viscosupplementation products, 8 pipeline products, 7 manufacturing companies, 3 marketing partners and supported with 82 tables and 61 figures is now available at .

With US continuing to hold the largest viscosupplementation market share, the market value will increase from approximately $1.76 billion in 2014 to a little under $2.64 billion by 2021, across the ten major markets of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China, and India. In addition to the US, the Asia-Pacific (APAC) region represents a promising avenue for volume growth in the viscosupplementation market. In Japan, the second largest viscosupplementation market, it is common for patients to have hyaluronic acid injections on a regular basis, with the therapy prescribed at a fraction of the cost to that in the US and Europe. China has also contributed to the significant increase in APAC viscosupplementation procedure volume over the past decade, and still has a substantial underserved population. The large patient pool, which is finally gaining access to advanced medical treatment as healthcare reform reaches China's rural regions, will be a key viscosupplementation market growth driver during the forecast period.

This 2015 research states that global viscosupplementation market growth will be driven by strong healthcare infrastructure, well-established reimbursement, and aggressive marketing efforts from the supply side, as well as the trend towards early intervention and the soaring demand for non-surgical osteoarthritis treatment. While the ten major markets are expected to increase in terms of both procedure numbers and revenues, the market in the five European countries (5EU: France, Germany, Italy, Spain, and the UK) is fairly mature and will experience slow expansion. Drug spending in Europe is currently limited by a weak economic recovery, low population growth, and continued efforts to reduce the public debt. Surgeons' dampened enthusiasm about viscosupplementation, along with reimbursement challenges and cost-containment pressures, will continue to negatively impact the 5EU viscosupplementation market expansion, which will be compounded by suppliers focusing on the fast-growing US and APAC regions.

Products of viscosupplementation market covered in this research include Adant, Arthrum, Curavisc, Durolane, Euflexxa, Fermathron, Gel-One, Go-On, Hyalgan, Hyalubrix and HyalOne, Jonexa, NeoVisc, Orthovisc and Monovisc , Ostenil, Recosyn, RenehaVis, Supartz/ARTZ, Suplasyn, Suvenyl, Synocrom, Synolis V-A, Synovial, Synvisc and Synvisc-One, Gel-Syn (IBSA Institut Biochimique S.A.), Cingal (Anika Therapeutics), Hydros-TA (Carbylan Therapeutics), Additional Indication for Synvisc-One (Sanofi), Hymovis (Fidia Farmaceutici S.p.A.), HA-NSAID Conjugates (Seikagaku Corporation), Additional Indication for Supartz/ARTZ (Seikagaku Corporation) and Clodronate-HA Conjugates (Abiogen Pharma). Manufacturers and marketing partners listed in this viscosupplementation market report are Anika Therapeutics, Chugai Pharmaceutical, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Meda AB, Sanofi, Seikagaku Corporation, Bioventus, DePuy Synthes and Zimmer-Biomet. Order a copy of MediPoint: Viscosupplementation - Global Analysis and Market Forecasts 2015 research report at .

"What Do Physicians Think" quotes from viscosupplementation market provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every viscosupplementation market organization allowing them to act on high quality information.

On a related note, another viscosupplementation market research titled Viscosupplementation - Pipeline Review, 2015 is a report that provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Viscosupplementation pipeline products. Companies covered in this viscosupplementation market pipeline report along with their pipeline products and ongoing clinical trials overview include Anika Therapeutics, Inc., BioPolymer GmbH & Co. KG, Carbylan Therapeutics, Inc., Chi2Gel Ltd., Cocoon Biotech, Inc., Flex Biomedical, Inc., Moebius Medical Ltd., OrthogenRx Inc., Synolyne Pharma and University of Kansas. Spread across 37 pages and supported with 49 tables and 5 figures, the Viscosupplementation - Pipeline Review, 2015 market research report is available at .

A third and regional viscosupplementation market research titled US Market for Hyaluronic Acid Viscosupplementation 2011-2021 is a 50 pages report says there are three forms of hyaluronic acid products available on the market: single-injection, three-injection and five-injection cycles. These products vary in their volumes and concentrations of sodium hyaluronate. The three-injection and five-injection products are well-established in the U.S. market. The first single-injection product was approved by the FDA in February 2009; the corresponding market has grown very rapidly. Read more at .

Explore more reports on medical devices market and pharmaceuticals industry at .

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Connect with Us: 

G+ / Google Plus:



RSS / Feeds:

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441

SOURCE RnR Market Research